Collaboration and License Agreements (Tables)

6 Months Ended

Jun. 30, 2024

Collaborations And License Agreement [Abstract]

Summary of Reconciliation of Closing Balance of Deferred Revenue Related to agreements

A reconciliation of the closing balance of deferred revenue related to the agreements is as follows (in thousands):

	Roche Collaboration Agreement			Takeda Collaboration Agreement			Astellas Strategic Rights Letter			Astellas Collaboration Agreement			Total
Balance as of December 31, 2022	$	31,749		$	9,307		$	—		$	—		$	41,056
Amounts received/invoiced		30,741			5,111			35,583			—			71,435
Revenue recognized		(50,285	)		(14,418	)		—			—			(64,703	)
Balance as of December 31, 2023	$	12,205		$	—		$	35,583		$	—		$	47,788
Amounts received/invoiced		74,540			—			—			50,000			124,540
Revenue recognized		(42,198	)		—			(11,861	)		(56	)		(54,115	)
Balance as of June 30, 2024	$	44,547		$	—		$	23,722		$	49,944		$	118,213